Daniel A. Pryor - Nov 15, 2022 Form 4 Insider Report for Enovis CORP (ENOV)

Role
EVP, Strategy & Business Dev.
Signature
/s/ Brian P. Hanigan, attorney-in-fact
Stock symbol
ENOV
Transactions as of
Nov 15, 2022
Transactions value $
-$641,578
Form type
4
Date filed
11/17/2022, 05:00 PM
Previous filing
Mar 9, 2022
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $0.001 Options Exercise $3.04M +67.4K +89.03% $45.06 143K Nov 15, 2022 Direct F1
transaction ENOV Common stock, par value $0.001 Sale -$3.68M -67.4K -47.1% $54.58 75.7K Nov 15, 2022 Direct F2, F3
holding ENOV Common stock, par value $0.001 932 Nov 15, 2022 By 401k plan
holding ENOV Common stock, par value $0.001 333 Nov 15, 2022 By trust for daughter
holding ENOV Common stock, par value $0.001 333 Nov 15, 2022 By trust for daughter
holding ENOV Common stock, par value $0.001 333 Nov 15, 2022 By trust for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENOV Employee Stock Option (right to buy) Options Exercise $0 -67.4K -100% $0.00* 0 Nov 15, 2022 Common stock, par value $.001 67.4K $45.06 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings reflect the adjustments that occurred as of April 4, 2022 in connection with the spin-off of ESAB Corporation by the Issuer. In connection with the spin-off, each outstanding restricted stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded down to the nearest whole unit. In addition, holdings have been updated to reflect the impact of the one-for-three reverse stock split effected by the Issuer on April 4, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F3 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.47 to $55.01, inclusive. The reporting person undertakes to provide to Enovis Corporation, any security holder of Enovis Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The option vests in equal installments on the first, second and third anniversaries of the grant date, which was 11/15/2015